Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

ClinicalTrials.gov ID: NCT04622319

Public ClinicalTrials.gov record NCT04622319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast or Axillary Lymph Nodes Following Neoadjuvant Therapy (DESTINY-Breast05)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk of disease recurrence. More effective treatment options are needed for this patient population. This study will examine the efficacy and safety of trastuzumab deruxtecan (T-DXd) compared with trastuzumab emtansine (T-DM1) in high-risk patients with residual invasive breast cancer following neoadjuvant therapy.

Study identification

NCT ID
NCT04622319
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
1,600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2020 (Actual)
Primary completion
Jul 2, 2025 (Actual)
Completion
Jun 20, 2028 (Estimated)
Last update posted
May 15, 2026

2020 – 2028

United States locations

U.S. sites
126
U.S. states
15
U.S. cities
97
Facility City State ZIP Site status
The Oncology Institute of Hope & Innovation Anaheim California 92801 —
Kaiser Permanente Anaheim California 92806 —
Kaiser Permanente Baldwin Park California 91706 —
Kaiser Permanente Bellflower California 90706 —
Kaiser Permanente Fontana California 92335 —
Orange Coast Blood and Cancer Care Fountain Valley California 92708 —
Kaiser Permanente Harbor City California 90710 —
Kaiser Permanente Irvine California 92618 —
Long Beach Memorial TCI Long Beach California 90806 —
Kaiser Permanente Los Angeles California 90027 —
Kaiser Permanente Ontario California 90710 —
Kaiser Permanente Panorama City California 91402 —
Kaiser Permanente Riverside California 92505 —
Kaiser Permanente San Diego California 92120 —
Kaiser Permanente San Marcos California 92078 —
Kaiser Permanente West Los Angeles California 90034 —
Kaiser Permanente Woodland Hills California 91367 —
SCRI FCS North- Altamonte Altamonte Springs Florida 32701 —
SCRI FCS South- Bonita Bonita Springs Florida 34135 —
SCRI FCS North- Brandon Cancer Center Brandon Florida 33511 —
SCRI FCS South- North Fort Myers Cape Coral Florida 33909 —
SCRI FCS North- Mease/Clearwater Clearwater Florida 33761 —
SCRI FCS South Fort Myers Florida 33901 —
SCRI FCS South- Colonial Fort Myers Florida 33905 —
SCRI FCS South- Gladiolus Fort Myers Florida 33908 —
SCRI FCS North- Gainesville Cancer Center Gainesville Florida 32605 —
Baptist MD Anderson Cancer Center Jacksonville Florida 32207 —
SCRI FCS North- Villages East Lady Lake Florida 32159 —
SCRI FCS South- Lakewood Ranch Lakewood Rch Florida 34211 —
SCRI FCS North- Largo/Highland Largo Florida 33770 —
SCRI FCS North- Lecanto Lecanto Florida 34461 —
SCRI FCS South- Naples West Naples Florida 34102 —
SCRI FCS South- Naples/Goodlette Naples Florida 34119 —
SCRI FCS North- New Port Richey New Port Richey Florida 34655 —
SCRI FCS North- Ocala Ocala Florida 34474 —
Orlando Health Ocoee Florida 34761 —
SCRI FCS North- Orange City Orange City Florida 32763 —
Orlando Health Orlando Florida 32806 —
SCRI FCS North- Orlando Downtown Orlando Florida 32806 —
SCRI FCS South- Port Charlotte Port Charlotte Florida 33980 —
SCRI FCS South- Sarasota-Cattleman Sarasota Florida 34232 —
SCRI FCS South-Sarasota-Downtown Sarasota Florida 34236 —
SCRI FCS North- Spring Hill Spring Hill Florida 34608 —
SCRI FCS North- St. Anthony's/St. Petersburg St. Petersburg Florida 33705 —
SCRI FCS North St. Petersburg Florida 33705 —
SCRI FCS North- Tampa Cancer Center Tampa Florida 33607 —
SCRI FCS North- Tavares Tavares Florida 32778 —
SCRI FCS South- Venice Healthpark Venice Florida 34292 —
Cleveland Clinic-Weston Weston Florida 33326 —
SCRI FCS North- Winter Park Winter Park Florida 32792 —
Elmhurst Memorial Hospital- Nancy W. Knowles Cancer Center Elmhurst Illinois 60126 —
Edward Cancer Center Naperville Illinois 60540 —
Edward Cancer Center Plainfield Plainfield Illinois 60585 —
University of Kentucky, Markey Cancer Center, Clinical Research Organization Lexington Kentucky 40536 —
Baptist Health Louisville Louisville Kentucky 40207 —
LSU Health Baton Rouge North Clinic Baton Rouge Louisiana 70805 —
Our Lady of the Lake Physician Group-Medical Oncology Baton Rouge Louisiana 70808 —
Mary Bird Perkins Cancer Center Baton Rouge Louisiana 70809 —
Ochsner Hematology Oncology North Shore - Covington (West Region) Covington Louisiana 70433 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
MedStar Franklin Square Medical Center-Harry and Jeanette Weinberg Cancer Institute Baltimore Maryland 21237 —
MedStar Franklin Square Cancer Center at Loch Raven Campus Baltimore Maryland 21239 —
Frederick Health-James M Stockman Cancer Center Frederick Maryland 21702 —
Maryland Oncology Hematology Silver Spring Maryland 20904 —
Holy Cross Hospital Silver Spring Maryland 20910 —
Montefiore Medical Center The Bronx New York 10461 —
Waverly Hematology Oncology Cary North Carolina 27518 —
UNC Cancer Care at Nash Rocky Mount North Carolina 27804 —
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 —
Cleveland Clinic - Hillcrest Cleveland Ohio 44195 —
Cleveland Clinic-Fairview Cleveland Ohio 44195 —
Cleveland Clinic Cleveland Ohio 44195 —
Cleveland Clinic South Pointe Warrensville Heights Ohio 44195 —
UPMC Upper St. Clair Bethel Park Pennsylvania 15102 —
UPMC Passavant Cranberry/North Cranberry Township Pennsylvania 16066 —
UPMC Erie Erie Pennsylvania 16505 —
AHN Cancer Inst at St Vincent Erie Pennsylvania 16544 —
UPMC Arnold Palmer-Mt View Greensburg Pennsylvania 15601 —
UPMC Pinnacle-Ortenzio Cancer Center Harrisburg Pennsylvania 17050 —
UMPC Pinnacle Pharmacy Harrisburg Pennsylvania 17109 —
AHN Cancer Insititute at Jefferson Jefferson Hills Pennsylvania 15025 —
AHN Cancer Institute at Forbes Monroeville Pennsylvania 15146 —
UPMC Monroeville Monroeville Pennsylvania 15146 —
UPMC Arnold Palmer-Mt Pleasant Mount Pleasant Pennsylvania 15666 —
UPMC Arnold Palmer-Norwin N. Huntingdon Pennsylvania 15642 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Magee Pittsburgh Pennsylvania 15213 —
UPMC St. Margaret Pittsburgh Pennsylvania 15215 —
AHN Cancer Inst at West Penn Pittsburgh Pennsylvania 15224 —
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
UPMC Passavant HOA Pittsburgh Pennsylvania 15237 —
UPMC Passavant OHA Pittsburgh Pennsylvania 15237 —
UPMC Uniontown Uniontown Pennsylvania 15401 —
UPMC Washington Washington Pennsylvania 15301 —
Reading Hospital, McGlinn Cancer Institute West Reading Pennsylvania 19611 —
AHN Cancer Institute at Wexford Wexford Pennsylvania 15090 —
UPMC Pinnacle-Memorial Cancer Center York Pennsylvania 17408 —
SCRI TO Nashville- Franklin Tennessee Oncology, PLLC Franklin Tennessee 37067 —
SCRI TO Nashville- Gallatin Tennessee Oncology, PLLC Gallatin Tennessee 37066 —
SCRI TO Nashville- Hendersonville Tennessee Oncology, PLLC Hendersonville Tennessee 37075 —
SCRI TO Nashville- Summit Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Regional Cancer Center at Indian Path Community Hospital Kingsport Tennessee 37660 —
SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC Lebanon Tennessee 37090 —
SCRI TO Nashville- St. Thomas Midtown Tennessee Oncology, PLLC Nashville Tennessee 37203 —
Tennessee Oncology Nashville / Sarah Cannon Nashville Tennessee 37203 —
SCRI TO Nashville- St. Thomas West Tennessee Oncology, PLLC Nashville Tennessee 37205 —
SCRI TO Nashville- Skyline Tennessee Oncology, PLLC Nashville Tennessee 37207 —
SCRI TO Nashville- Southern Hills Tennessee Oncology, PLLC Nashville Tennessee 37211 —
SCRI TO Nashville- Smyrna Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
Houston Methodist Baytown Baytown Texas 77521 —
Houston Methodist Houston Texas 77030 —
Houston Methodist Willowbrook Houston Texas 77070 —
Houston Methodist West Houston Texas 77094 —
Houston Methodist Clear Lake Nassau Bay Texas 77058 —
Houston Methodist Sugarland Sugar Land Texas 77479 —
Houston Methodist Woodlands The Woodlands Texas 77385 —
Wellmont Medical Associates Oncology & Hematology Bristol Virginia 24201 —
University of Virginia Charlottesville Virginia 22908 —
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298 —
MultiCare Cancer Center Aurburn Auburn Washington 98002 —
MultiCare Regional Cancer Center - Gig Harbor Gig Harbor Washington 98335 —
MultiCare Cancer Center Puyallup Puyallup Washington 98372 —
MultiCare Institute for Research & Innovation Spokane Washington 99204 —
MultiCare Institute for Research & Innovation Spokane Washington 99218 —
MultiCare Cancer Center Tacoma Tacoma Washington 98405 —
West Virginia University Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 356 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04622319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04622319 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →